The research, published in Cosmetics , demonstrated that GHK-Cu: Increased expression of genes encoding glutathione S-transferase, catalase, and heme oxygenase-1 enzymes that detoxify reactive oxygen species (ROS)
Friedrichsen M, Breitschaft A, Tadayon S, et al
Insurance Barriers: May not cover for weight loss (only approved for diabetes) Requires type 2 diabetes diagnosis for coverage Extensive prior authorization requirements May require trying other medications first High copays even with coverage Supply Shortages: Both Mounjaro and Zepbound have experienced periodic shortages since launch, making consistent access difficult
Some states require additional documentation or consent forms for telehealth visits
Higher doses correlate with a greater likelihood of side effects
doi:10.1161/atvbaha.119.313286